ADPKD Clinical Trials

6 recruiting

ADPKD Trials at a Glance

9 actively recruiting trials for adpkd are listed on ClinicalTrialsFinder across 6 cities in 10 countries. The largest study group is Phase 2 with 1 trial, with the heaviest enrollment activity in Leuven, Beijing, and Berlin. Lead sponsors running adpkd studies include IRCCS Azienda Ospedaliero-Universitaria di Bologna, Jemincare, and Children's Hospital of Philadelphia.

Browse adpkd trials by phase

Treatments under study

About ADPKD Clinical Trials

Looking for clinical trials for ADPKD? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new ADPKD trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about ADPKD clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting

The German ADPKD Tolvaptan Treatment Registry

ADPKD (Autosomal Dominant Polycystic Kidney Disease)
University of Cologne2,000 enrolled12 locationsNCT02497521
Recruiting
Phase 3

HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their Quality of Life

ADPKD
University Medical Center Groningen300 enrolled12 locationsNCT05373264
Recruiting

Hypertension in Children and Young People at Risk of Autosomal Dominant Polycystic Kidney Disease

Autosomal Dominant Polycystic Kidney Disease (ADPKD
King's College London200 enrolled1 locationNCT07260071
Recruiting

Somatosensory Phenotyping of ADPKD

PainADPKD
Universitaire Ziekenhuizen KU Leuven150 enrolled1 locationNCT06970028
Recruiting
Phase 2

Trial of JMKX003142 in Participants With Rapidly Progressive Autosomal Dominant Polycystic Kidney Disease (ADPKD)

ADPKD (Autosomal Dominant Polycystic Kidney Disease)
Jemincare135 enrolled1 locationNCT06800651
Recruiting

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Study

ADPKD
Children's Hospital of Philadelphia300 enrolled4 locationsNCT04338048
Recruiting

Kidney Sodium Functional Imaging

Chronic Kidney DiseaseADPKDNephrolithiasis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's200 enrolled1 locationNCT05014178
Recruiting

Analysis of Patients With Autosomal Dominant Polycystic Kidney

ADPKDAutosomal Dominant Polycystic Kidney
IRCCS Azienda Ospedaliero-Universitaria di Bologna180 enrolled1 locationNCT06759142
Recruiting

Genetics in the Progression of Nephropathies

HypertensionHematologic MalignancyCKD+5 more
Ospedale San Raffaele10,000 enrolled1 locationNCT06416761